Invenomic Capital Management’s Triple-S Management Corporation GTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-243,208
Closed -$8.68M 192
2021
Q4
$8.68M Hold
243,208
1.85% 14
2021
Q3
$8.6M Buy
243,208
+15,595
+7% +$445K 2.79% 4
2021
Q2
$5.07M Buy
227,613
+127,828
+128% +$3.17M 1.21% 14
2021
Q1
$2.6M Buy
+99,785
New +$2.46M 0.58% 36

Invenomic Capital Management's GTS Position: Q1 2022 in Review

Invenomic Capital Management sold out of Triple-S Management Corporation (GTS) in Q1 2022, closing a stake of 243,208 shares — an estimated $8.68M sold.

Invenomic Capital Management first reported a position in GTS in Q1 2021 and held it in 4 quarters. The position peaked at $8.68M in Q4 2021. 0 funds tracked by Wall St. Rank hold GTS as of Q1 2022.

  • Invenomic Capital Management reported no remaining Triple-S Management Corporation position as of Q1 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 243,208 Triple-S Management Corporation shares in Q1 2022, an estimated $8.68M.
  • Invenomic Capital Management first reported a position in Triple-S Management Corporation in Q1 2021 and held it in 4 quarters.
  • Invenomic Capital Management's Triple-S Management Corporation position peaked at $8.68M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Triple-S Management Corporation as of Q1 2022.

Based on Invenomic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.